Ekansh Mittal

eClerx Services (NSE – ECLERX) – Strong operating performance and reasonable valuations

Dear Readers, eClerx is a Knowledge and Business Process Outsourcing (“KPO”/”BPO”) company providing operational support, data management, and analytics solutions to over 50 Global Fortune 1000 clients, including many of the world’s leading Financial Services, E-commerce, Retail and Distribution, Broadcast, Cable and Telco, Interactive Media and Entertainment, Travel and Leisure, and Software Vendor companies. Incorporated in 2000, eClerx is India’s first publicly listed KPO Company. The company provides its services across 3 segments – cable and telecommunication, financial services, and…

Read More

Reliance Mediaworks – Likely to de-list around 65 (CMP – 55) in 1 month from now

Dear Readers, Anil Ambani is on de-listing spree, first it was Reliance Broadcast Network (RBN) and now Reliance Mediaworks. Though it’s difficult to make money in ADAG stocks, however the way RBN’s delisting panned out (RBN was recommended to Alpha + members @ 52 in Oct’13 with successful exit @ 66), it’s like betting on fixed matches. Recently RBN successfully concluded its reverse book building and the promoters of the company (also the promoters of Reliance Mediaworks) have offered Rs 70/- per…

Read More

Caplin Point Laboratories – A high quality Pharmaceutical stock

Dear Readers, In this post we would like to discuss a very small cap stock Caplin Point Laboratories (BSE Code – 524742). As mentioned in one of our previous posts, small and micro cap stocks are fraught with risks, however quick decision making and keeping a strong tab on the performance of such companies can also result in substantial gains. Caplin Point – Basic details Caplin Point is a debt free company with a market cap of 215 crores. The company’s…

Read More

[Report]: Feb’14 Pharmaceutical alpha stock – Good Company and great valuations

Feb’14 Alpha stock – A good Pharma company with great valuations Dear Readers, On 25th Feb’14 we released long/medium term investment recommendation for our Alpha and Alpha + members and would like to share with you details on the same especially if you like our research and our focus on high quality companies run by good management. Our last recommendation from Pharmaceutical Industry was IPCA Laboratories in Nov’12 at Rs 445 and the stock has appreciated by 100% since then to current…

Read More